Navigation Links
USC biomedical team to participate in $6 million low vision project
Date:10/5/2007

An interdisciplinary team of biomedical researchers from the USC Viterbi School, the College and the Keck School of Medicine of USC has received a $6-million Bioengineering Research Partnership grant from the National Institutes of Health (NIH) to begin designing visual aids for millions of older adults who suffer from significant vision loss.

The USC team, led by Norberto Grzywacz, professor of biomedical engineering in the Viterbi School and director of the USC Center for Vision Science and Technology, will join other researchers from Harvard Medical School and the University of Houston School of Optometry to address low vision problems caused by neural pathologies, such as macular degeneration and other diseases affecting the retina. Many of these vision problems are prevalent in older adults and cannot be fully corrected with ordinary lenses, medical treatment or surgery.

"Aging, injuries and diseases can all cause low vision, but the leading causes among older adults and the elderly are impairments such as age-related macular degeneration (AMD)," said Grzywacz, principal investigator on the five-year project, who also directs the USC Neuroscience Graduate Program. Our dream is to build devices like intelligent glasses or intelligent television displays that can improve these peoples lives.

AMD is a condition that usually develops in older adults and the elderly, and gradually destroys the central vision of the eye and an individuals ability to see fine detail. AMD patients quite often lose their ability to read, recognize faces and drive.

With an aging population, the incidence of AMD is on the rise. According to Grzywacz, approximately 3.5 percent of people in industrialized countries over the age of 75 have AMD.

That percentage rises to a staggering 18.5 percent for people over 85 years old, he said. AMD is also responsible for about 50 percent of all cases of registered blindness in industrialized countries.

The statistics are just as daunting in the United States. According to the National Eye Institute (NEI), approximately 1.7 million Americans have some form of AMD. Mark Humayun, an AMD expert in the USC Viterbi School of Engineering and the Keck School of Medicine of USC, predicts that by 2020, that number will climb to nearly 3 million. At the same time, an additional 8 million people will have clinical signs of AMD.

The NIH project will concentrate on designing visual displays that will help these people, who have lost their central vision and must rely on peripheral vision to see.

We plan to use some of the techniques of computer vision and computational neuroscience to build visual displays that will enhance certain parts of an image enough so that a person with AMD will be able to digest the visual information better, Grzywacz said. We arent concerned with the optics of the eye in low vision that can be corrected with glasses or surgery. Rather, our preoccupation is with the nervous system and the way in which the brain processes information.

The nervous system has been damaged in people with low vision and lacks some kinds of neurons that process information, he said. In AMD, for example, people lack central photoreceptors, the neurons that transduce light energy into electrochemical signals, the means of brain communication. Grzywacz hopes to design visual displays that will compensate for that neural loss.

As part of the work, engineering faculty in USCs Center for Vision Science and Technology will improve visual displays in two ways: first, they will enhance contrast in scenes and suppress background noise (irrelevant details) that might confuse a visually-impaired person; second, they will design displays that brighten the contours of objects in a scene, creating a cartoon of outlines that would be more recognizable by someone with poor eyesight.

Gerard Medioni of the Viterbi School Computer Science Department will lead the first task of building displays with region-specific contrast enhancement display. He will work with DXO Labs to modify and extend an already existing system that was developed for photography, emphasizing visibility rather than aesthetics. In standard photography, a camera adjusts its light sensitivity to the overall luminosity in a scene, so some objects will come out much darker than the brightest object in the picture. In the contrast-enhanced display, all regions of the scene would appear equally well lit, regardless of how dark or light they actually are.

When you lose your central vision, you lose the ability to use the fovea, which is responsible for the perception of sharp details, Grywacz said. This is a region with a high concentration of cone photoreceptors.

Once that region is damaged, an individual can only see in the peripheral region of the retina, which has far fewer cone photoreceptors and can only deliver information of low resolution to the brain, he said. The near periphery is inferior to the fovea and gets confused when too many details appear in the scene; scientists call this the masking and crowding effects.

To combat that reduced ability to see sharp details, a second team of researchers will use automatic techniques to outline and simplify the main objects in a scene, as in a cartoon, to increase their visibility and salience. These simplified objects may be more easily recognizable by subjects with low vision, said Bartlett Mel, associate professor of biomedical engineering in the Viterbi School, who will lead the effort.

In the third phase of the study, a team of psychologists and clinicians from the USC College, Keck School of Medicine, Harvard Medical School and University of Houston School of Optometry will develop and administer tests to measure the effectiveness of these new visual display systems. This team has expertise in blindness and low vision, and in the development of visual aids.

They will administer a battery of high-level vision tests to probe psychophysically visual functions, such as recognition of objects, faces and scenes. Other, lower-level tests will help the team determine whether subjects have better visual acuity, contrast sensitivity, visual fields, color vision and reading ability.

The patients will also be trained in techniques of perceptual learning to make the best use of the devices; statistical learning tools built into the devices will adapt automatically to the needs of the patients. Bosco Tjan of the USC College Psychology Department, Susana Chung from the University of Houston, and Eli Peli from Harvard Medical School will lead that effort.

Other USC faculty working on the NIH study include Irving Biederman of the College, who is an expert in object, face, and scene recognition; Zhong-Lin Lu of the College and Viterbi School, who specializes in motion perception and perceptual learning; and AMD specialist Dr. Mark Humayun, who holds joint appointments in the Keck School of Medicine of USC Department of Ophthalmology and the Viterbi School of Engineering.


'/>"/>

Contact: Diane Ainsworth
dainswor@usce.edu
213-821-5808
University of Southern California
Source:Eurekalert

Related biology news :

1. Automatic extraction of gene/protein biological functions from biomedical text
2. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
3. Scientists create digital bacteria to forge advances in biomedical research
4. Boston University biomedical engineers win major grant for pursuit of the $1,000 Genome
5. Yale participates in global human genome initiative
6. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
7. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
8. Six million Africans face famine because of locusts, drought
9. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
10. Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils
11. $5.1 billion would save 6 million children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology: